Financial Snapshot

Revenue
$771.3M
TTM
Gross Margin
45.62%
TTM
Net Earnings
-$296.7M
TTM
Current Assets
Q4 2022
Current Liabilities
Q4 2022
Current Ratio
220.32%
Q4 2022
Total Assets
Q4 2022
Total Liabilities
Q4 2022
Book Value
$1.544B
Q4 2022
Cash
Q4 2022
P/E
-11.34
Mar 03, 2023 EST
Free Cash Flow
-$163.3M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2022 2021 2020 2019 2018 2017

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2022 2021 2020 2019 2018 2017

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2022 2021 2020 2019 2018 2017

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2022 2021 2020 2019 2018 2017

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2022 2021 2020 2019 2018 2017

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2022 2021 2020 2019 2018 2017

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2022 2021 2020 2019 2018 2017

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $3.3657 Billion

About 1Life Healthcare Inc

1Life Healthcare, Inc. engages in the provision of healthcare membership services. The company is headquartered in San Francisco, California. The company went IPO on 2020-01-31. The firm provides a membership-based primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live and click. Its annual membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. Additionally, it has also developed clinically integrated partnerships with health networks, for better coordinating more timely access to specialty care when needed by members and employers through clinical and digital integration. The company provides services such as wellness and prevention, chronic conditions, children and family, mental health, LGBTQ services, urgent case, and sexual health.

Industry: Services-Offices & Clinics of Doctors of Medicine Peers: AGILITI, INC. \DE AMEDISYS INC AMN HEALTHCARE SERVICES INC Astrana Health, Inc. CORVEL CORP CVS HEALTH Corp LifeStance Health Group, Inc. MSP Recovery, Inc. Privia Health Group, Inc. Premier, Inc.